首页>
外国专利>
COMBINED USE OF CLINICAL RISK FACTORS AND MOLECULAR MARKERS FOR THROMBOSIS FOR CLINICAL DECISION SUPPORT
COMBINED USE OF CLINICAL RISK FACTORS AND MOLECULAR MARKERS FOR THROMBOSIS FOR CLINICAL DECISION SUPPORT
展开▼
机译:临床风险因素和分子标记物联合用于血栓形成的临床决策支持
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to an apparatus and method for clinical decision support to identify patients at high risk of t hrombosis based on a combination of clinical risk factors and molecular markers e.g. protein concentrations. These clinical risk factors and molecular markers are combined in a machine learning based algorithm which returns an output value relating to an estimated risk of a thrombosis event in the future.
展开▼